Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
出版年份 2018 全文链接
标题
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-16
DOI
10.1038/s41416-018-0159-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices
- (2017) Lori J. Pierce et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ischemic Cardiac Events Following Treatment of the Internal Mammary Nodal Region Using Contemporary Radiation Planning Techniques
- (2017) Robert T. Dess et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005
- (2017) Jens Christian Rehammar et al. RADIOTHERAPY AND ONCOLOGY
- Evaluation of Heart Dose for Left-Sided Breast Cancer Patients Over an 11-Year Period Spanning the Transition From 2-Dimensional to 3-Dimensional Planning
- (2016) Jennifer S. Chang et al. Clinical Breast Cancer
- Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors
- (2016) Naomi B. Boekel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation of the Internal Mammary Nodes: Is There a Benefit?
- (2016) Bruce G. Haffty et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study
- (2016) Paaladinesh Thavendiranathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
- (2016) Frederika A. van Nimwegen et al. JOURNAL OF CLINICAL ONCOLOGY
- DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
- (2016) Lise Bech Jellesmark Thorsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013
- (2015) Carolyn W. Taylor et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
- (2015) David J. Cutter et al. JNCI-Journal of the National Cancer Institute
- Regional Nodal Irradiation in Early-Stage Breast Cancer
- (2015) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
- (2015) Philip M. Poortmans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease After Hodgkin Lymphoma Treatment
- (2015) Frederika A. van Nimwegen et al. JAMA Internal Medicine
- Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
- (2015) David J. Cutter et al. JNCI-Journal of the National Cancer Institute
- Cardiovascular disease after cancer therapy
- (2014) Berthe M.P. Aleman et al. EJC SUPPLEMENTS
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- Cardiac Complications of Thoracic Irradiation
- (2013) Catherine Jaworski et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2012) Edward H. Romond et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
- (2012) John R Mackey et al. LANCET ONCOLOGY
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897
- (2008) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started